Mobia Medical (NASDAQ:MOBI) Upgraded by Zacks Research to “Hold” Rating

Zacks Research upgraded shares of Mobia Medical (NASDAQ:MOBI) to a hold rating in a research note issued to investors on Wednesday morning,Zacks.com reports.

Several other research firms have also recently commented on MOBI. BTIG Research assumed coverage on Mobia Medical in a research note on Tuesday. They issued a “buy” rating and a $19.00 target price for the company. Wolfe Research assumed coverage on Mobia Medical in a research note on Tuesday. They issued an “outperform” rating for the company. Bank of America assumed coverage on Mobia Medical in a research note on Tuesday. They issued a “buy” rating and a $16.00 target price for the company. The Goldman Sachs Group assumed coverage on Mobia Medical in a research note on Tuesday. They issued a “buy” rating and a $31.00 target price for the company. Finally, Wall Street Zen raised Mobia Medical to a “hold” rating in a research note on Saturday, May 16th. Five analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $20.25.

Mobia Medical Stock Up 0.8%

NASDAQ MOBI opened at $13.84 on Wednesday. The firm has a market capitalization of $457.90 million, a PE ratio of 66.00 and a beta of 2.84. Mobia Medical has a 52 week low of $10.19 and a 52 week high of $14.77.

Mobia Medical (NASDAQ:MOBI) last released its earnings results on Thursday, June 4th. The company reported $999.00 EPS for the quarter.

Insiders Place Their Bets

In related news, Director William T. Harrington purchased 533,333 shares of Mobia Medical stock in a transaction dated Monday, May 11th. The shares were acquired at an average cost of $15.00 per share, for a total transaction of $7,999,995.00. Following the transaction, the director directly owned 2,006,716 shares of the company’s stock, valued at approximately $30,100,740. This trade represents a 36.20% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder Osage University Gp Iii, Llc purchased 533,333 shares of Mobia Medical stock in a transaction dated Monday, May 11th. The stock was bought at an average price of $15.00 per share, for a total transaction of $7,999,995.00. Following the completion of the transaction, the insider directly owned 2,006,716 shares in the company, valued at $30,100,740. The trade was a 36.20% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased 1,268,332 shares of company stock worth $19,024,980 over the last three months.